Pharmaceutical Industry Information Portal


All posts by tag


Yale, JDRF and NexImmune, $600,000 grant for diabetes research

NexImmune, Inc., Yale and JDRF have begun a two-year project to explore the use of NexImmune’s AIM nanoparticles in combination with an anti-CD3 mAb...

Biocon Biologics gets EMA’s backing for Inpremzia

Biocon Biologics Ltd. (BBL), a subsidiary of Biocon Ltd., announced today the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has...

New technologies are an integral part of diabetes management

A large population of people living with type 1 diabetes are set to be offered new technology to help them manage their condition and...

Expert Articles